FDA InspectionBaxter Pharmaceutical Solutions, LLC
Baxter Pharmaceutical Solutions, LLC – FDA Inspection, Feb 20, 2024
Record Details
This FDA Inspection record concerns Baxter Pharmaceutical Solutions, LLC, with an inspection on February 20, 2024, issued by the Detroit District Office, covering human drugs.
ID · 1096b217-7488-424a-96e2-821302093f1b
Inspection Facts
- Inspection number
- 1230675
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Baxter Pharmaceutical Solutions, LLC
19| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2025 | Not classified | Detroit District Office | Blood and Blood Products |
| September 24, 2024 | Not classified | Detroit District Office | |
| July 26, 2024 | Not classified | Detroit District Office | |
| February 17, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 10, 2021 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Or discuss it with
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Baxter Pharmaceutical Solutions, LLC document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA